(Boursier.com) — Nanobiotix a French biotechnology company in advanced clinical development, pioneering physics-based approaches to expand treatment options for cancer patients, today announces that it will release its financial results for the first half of 2023, after the close of the American market.
This release will be followed by a conference call and live webcast on Wednesday, September 27, 2023, at 2:00 p.m. CEST / 8:00 a.m. EDT. During the conference call, Laurent Levy, Chairman of the Management Board, and Bart Van Rhijn, Financial Director, will briefly review the Company’s results for the first half of 2023, and will take stock of its activity before answering questions from the audience. participants.
©2023 Boursier.com